Compulsary Health Insurance Offsets Impact Of Price Cuts

BMI View: Public regulatory bodies in emerging markets will become increasingly involved in reducing the prices of pharmaceuticals. Multinational drugmakers are looking to offset fiscal austerity measures and stagnant sales growth in Europe and the US by moving into the emerging markets. However, price control measures will eventually follow them from the developed markets. Pharmaceutical distributers in Kuwait should expect to have their profit margins squeezed by drug price control measures. With mark-ups between cost, insurance and freight (CIF) and consumer prices averaging 50%, there has already been much improvement in pricing since 2010 but there is still room for

To read the full article, please choose one of the following options: